Back to SGEN Stock Lookup

Seattle Genetics (SGEN) – StreetInsider.com Reports

Dec 6, 2016 06:18 AM Seattle Genetics (SGEN), Bristol-Myers (BMY) Present First Data from ADCETRIS + Opdivo Phase 1/2 in r/r HL
Dec 5, 2016 01:05 PM Seattle Genetics (SGEN) Offers LT Follow-up Data on ADCETRIS in T-Cell Lymphomas; Median CR Duration Not Reached
Dec 5, 2016 06:36 AM Seattle Genetics (SGEN), Takeda Pharma Announce Positive Data from ADCETRIS Phase 3 in CD30-Expressing Cutaneous T-Cell Lymphoma
Nov 29, 2016 08:18 AM UPDATE: Barclays Downgrades Seattle Genetics (SGEN) to Equalweight
Nov 10, 2016 08:07 AM Seattle Genetics (SGEN) Granted FDA Breakthrough Therapy Designation for ADCETRIS
Nov 8, 2016 08:04 AM Seattle Genetics (SGEN), Takeda Announce Completion of ADCETRIS Phase 3 Enrollment in rontline Mature T-cell Lymphoma
Oct 27, 2016 06:11 PM After-Hours Stock Movers 10/27: (CVRS) (SMCI) (GIMO) (LOGM) (CRUS) (HBI) (VRSN) (CBI) (SGEN) (ACTG) (CY) Higher; (SYMX) (YRCW) (SYNA) (CENX) (MXK) (ATEN) (MLNX) (ASNG) (AMZN) Lower
Oct 27, 2016 04:13 PM Seattle Genetics (SGEN) Tops Q3 EPS by 6c
Oct 26, 2016 02:46 PM Trading Radar for 10/27: Alphabet (GOOG), Amazon (AMZN), Twitter (TWTR) Ford (F), Baidu.com (BIDU) Report
Oct 21, 2016 09:05 AM Leerink Partners Remains Bullish Ahead of Seattle Genetics's (SGEN) 3Q Report
Oct 20, 2016 08:07 AM Seattle Genetics (SGEN) Updates on Multiple Presentations Made at ISHL
Oct 13, 2016 09:20 AM Pre-Open Stock Movers 10/13: (OCUL) (ESRP) (ULTA) Higher; (FLDM) (TGTX) (MELI) Lower (more...)
Oct 12, 2016 05:20 PM Seattle Genetics (SGEN) Files 44.1M Share Common Stock Shelf for Selling Shareholders
Oct 7, 2016 02:09 PM Leerink Says Seattle Genetics' (SGEN) Pipeline Value Drivers Still Underappreciated
Oct 7, 2016 09:02 AM Seattle Genetics (SGEN), Agensys Present Updated ASG-22ME, ASG-15ME Data at ESMO 2016
Oct 4, 2016 08:05 AM Seattle Genetics (SGEN) Names New CTO, SVP
Sep 15, 2016 06:52 AM Goldman Sachs Upgrades Seattle Genetics (SGEN) to Neutral
Aug 1, 2016 12:12 PM Streetinsider.com's Hot Lunchtime Reads 8/1: (AXTA) (SCTY) (XON) (SGEN)
Aug 1, 2016 10:58 AM Seattle Genetics (SGEN) PT Raised to $52 at Leerink Partners
Aug 1, 2016 06:59 AM Seattle Genetics (SGEN), Takeda Announce Statistically Significant Phase 3 ALCANZA Data
Jul 27, 2016 07:22 AM Cantor Fitzgerald Downgrades Seattle Genetics (SGEN) to Hold
Jul 26, 2016 04:52 PM Seattle Genetics (SGEN) Tops Q2 EPS by 9c
Jul 25, 2016 02:40 PM Trading Radar for 7/26: Apple (AAPL), McDonald's (MCD), 3M (MMM), Caterpillar (CAT), Verizon (VZ), [Conference Call] Under Armour (UA) Report
Jul 18, 2016 10:05 AM Seattle Genetics (SGEN), Takeda Announces Publication of Final ADCETRIS Phase 2 Data in r/r Hodgkin Lymphoma
Jul 6, 2016 08:11 AM Takeda Announces Receipt of EC Approval for ADCETRIS as Post-Transplant Hodgkin Lymphoma Treatment (SGEN)
Jun 29, 2016 07:56 AM Credit Suisse Sees $157B of FCF Through 2019 Available for M&A in Biotech/Pharma Sector
Jun 28, 2016 07:52 AM Seattle Genetics (SGEN): Adcetris Could Become a Blockbuster - Needham
Jun 24, 2016 11:13 AM Needham & Company Weighs in on Brexit Biotech Impact (ACAD) (GILD0 (ICPT) (SGEN)
Jun 6, 2016 08:05 AM Seattle Genetics (SGEN), Astellas Pharma Will Present ASG-15ME, ASG-22ME Data at ASCO
Apr 28, 2016 04:34 PM Seattle Genetics (SGEN) Misses Q1 EPS by 6c
Apr 27, 2016 12:45 PM Trading Radar for 4/28: Ford (F), Amazon (AMZN), Viacom (VIAB), LinkedIn (LNKD), Pandora (P), Aetna (AET) Report
Apr 18, 2016 08:02 AM Seattle Genetics (SGEN) Highlights Data SupportING ADC Immuno-Oncology programs at AACR
Mar 2, 2016 04:44 PM SunTrust Starts Seattle Genetics (SGEN) at Neutral
Feb 22, 2016 08:12 AM Seattle Genetics (SGEN) Initiates Phase 1/2 Trial of Vadastuximab Talirine Combination for Patients with Untreated MDS
Feb 10, 2016 08:57 AM Seattle Genetics (SGEN): In Line ADCETRIS Sales Lead to PT Reduction at Piper Jaffray
Feb 10, 2016 07:26 AM Cantor Fitzgerald Upgrades Seattle Genetics (SGEN) to Buy
Feb 9, 2016 04:05 PM Seattle Genetics (SGEN) Tops Q4 EPS by 2c
Feb 8, 2016 02:35 PM Trading Radar for 2/9: Disney (DIS), Coca-Cola (KO), Viacom (VIAB), Nuance (NUAN), CVS Health (CVS) Report
Feb 4, 2016 10:16 AM Barclays Starts Seattle Genetics (SGEN) at Overweight
Feb 4, 2016 08:10 AM Seattle Genetics (SGEN) to Receives $20M Milestone Payment From ADCETRIS Collaboration with Takeda
Jan 21, 2016 06:26 AM Credit Suisse Starts Seattle Genetics (SGEN) at Outperform
Dec 23, 2015 08:01 AM Seattle Genetics (SGEN), Bristol-Myers Squibb (BMY) Initiate ADCETRIS + Opdivo Phase 1/2 in DLBCL
Dec 10, 2015 08:07 AM Seattle Genetics (SGEN) Presents Ongoing SGN-LIV1A Phase 1 Data at SABCS
Dec 8, 2015 08:15 AM Seattle Genetics (SGEN) Delivers at ASH - Needham & Company
Dec 7, 2015 04:32 PM Seattle Genetics (SGEN) ADCETRIS Frontline Non-Hodgkin Lymphoma Data Presented at ASH
Dec 7, 2015 06:28 AM Seattle Genetics (SGEN) Announces Presentation of SGN-CD19A Data in NHL a ASH
Nov 23, 2015 08:14 AM Seattle Genetics (SGEN) Initiates SGN-CD33A Phase 1/2 in AML
Nov 18, 2015 09:00 AM UPDATE: Goldman Sachs Sees 27% Downside in Seattle Genetics (SGEN), Initiates Coverage With Sell Rating
Oct 30, 2015 01:12 PM Seattle Genetics (SGEN) Recorded Record Sales Following Label Expansion; Needham & Company Reiterates Buy
Oct 30, 2015 07:06 AM Piper Jaffray Upgrades Seattle Genetics (SGEN) to Neutral

Back to SGEN Stock Lookup